Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report)’s share price passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $7.25 and traded as low as $6.52. Nxera Pharma shares last traded at $6.52, with a volume of 200 shares changing hands.
Nxera Pharma Trading Up 5.9 %
The company’s fifty day simple moving average is $7.24 and its 200 day simple moving average is $8.58.
About Nxera Pharma
Nxera Pharma Co, Ltd. develops and sells biopharmaceutical products in Japan, Switzerland, the United States, Bermuda, and the United Kingdom. Its product portfolio products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair and Breezhaler for the treatment of asthma; ORAVI, a novel formulation for the treatment of oropharyngeal candidiasis; and PIVLAZ for the treatment of cerebral vasospasm indications.
Further Reading
- Five stocks we like better than Nxera Pharma
- How to Use the MarketBeat Excel Dividend Calculator
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- CD Calculator: Certificate of Deposit Calculator
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Nxera Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nxera Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
